23 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
reputation for quality, their industry leadership and our shared commitment to develop innovative life science tools. We remain committed to our … and therapeutic applications. MyChem develops integrated partnerships with customers across the globe to provide premium reagents and innovative services
8-K
EX-99.1
a9hm2qz17wk4gxai3
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
ri9y31v2f
12 May 21
Quarterly report
4:26pm
DEF 14A
ssftznr69r1
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
cqz9y82kbydr2
9 Apr 21
Preliminary proxy
4:16pm
424B4
b3epdvve0jd8 ja
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
78e3s43i
25 Mar 21
Draft registration statement
12:00am
10-K
wzs9up
22 Mar 21
Annual report
4:22pm
424B4
cp9muwv6hstnf g0mqrq
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
5vab5
29 Oct 20
IPO registration
5:04pm
DRS/A
9i18png7un7he 0hhn
23 Oct 20
Draft registration statement (amended)
12:00am
DRSLTR
zpgo3s9
14 Oct 20
Correspondence regarding draft registration statement
12:00am